Product Description: Timigutuzumab (GEXMab73) is a humanized monoclonal antibody that targets ErbB2. Timigutuzumab can be used for the research of cancer[1].
Applications: Cancer-Kinase/protease
Formula: N/A
References: [1]Santis RD. Anti-ErbB2 immunotherapeutics: struggling to make better antibodies for cancer therapy. MAbs. 2020 Jan-Dec;12(1):1725346.